USpolicy

News

A rendering of AstraZeneca's manufacturing facility in Virginia

AZ starts work on Virginia plant in $50bn US investment plan

The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ground on a facility in Virginia.

News

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

UK and US agencies team up for medtech, AI regulation

The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical technologies and AI.

News

Regeneron's Libtayo stakes out new territory in skin cancer

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

News

Boehringer bags FDA okay for new pulmonary fibrosis drug

Boehringer's successor to blockbuster IPF therapy Ofev has been approved by the FDA as Jascayd, but will the new drug be a commercial success?

News

Acting CDC director says MMR jabs should be split

The acting director of the CDC, Jim O’Neill, has been sharply criticised after saying the MMR vaccine should be separated into three individual shots.

AZ starts work on Virginia plant in $50bn US investment plan

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

UK and US agencies team up for medtech, AI regulation

Regeneron's Libtayo stakes out new territory in skin cancer

Boehringer bags FDA okay for new pulmonary fibrosis drug

Acting CDC director says MMR jabs should be split

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

USpolicy

Editor's Picks